The new research
The aim of the study is to demonstrate the performance of the neuCA15.3 test for monitoring treatment response and/or disease recurrence compared to an FDA cleared CA15-3 test (Roche Elecys CA15-3 II).
Is anyone expecting any significantly different data - we've already been told specificity and sensitivity %'s - what exactly will the new study tell us?
The new researchThe aim of the study is to demonstrate the...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
0.005(1.02%) |
Mkt cap ! $45.54M | |||
| Open | High | Low | Value | Volume |
| 49.0¢ | 50.0¢ | 49.0¢ | $15.36K | 31.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 49.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 11463 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
49.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 49.5¢ | 49.5¢ | 49.5¢ | 180 | ||
| Last updated 13.19pm 03/05/2024 ? | |||||
| IIQ (ASX) Chart |